
Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
Steven Spielberg's 'Disclosure Day' trailer drops: What we know about the alien movie16.12.2025 - 2
The Force of Care: Living with Goal01.01.1 - 3
The Magnificence of Do-It-Yourself Skincare: Regular Recipes and Tips01.01.1 - 4
The most effective method to Execute a Lung-Solid Eating routine After a Cellular breakdown in the lungs Finding17.10.2023 - 5
The Solution to Innovative Peculiarity: Analyzing the Fate of Mankind07.07.2023
Consumers advised to dispose of 19 cooking pans due to lead leaching risk, FDA reports
Amy Poehler's podcast is a hit. It's also a Trojan horse for talking about women and aging.
Wonderful Sea shores All over the Planet
Lebanon says Israeli strike killed 13 people near Palestinian refugee camp
CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation
I thought I knew the night sky, but what I saw from the Canary Islands left me speechless
Mississippi Insight for Jan. 11, 2026
Step by step instructions to Choose the Right Auto Crash Legal counselor for Your Case
Human evolution’s biggest mystery has started to unravel. How 2025 tipped the scales













